The National Institute for Allergy and Infectious Diseases (NIAID) has awarded contracts worth $56.1 million to four companies for advanced development of anthrax antitoxins, as well as therapeutics and antibiotics for use against plague and tularemia. The largest award, $20.7 million, went to Nanotherapeutics, Inc., to advance the development of a new approach to formulate an existing antibiotic called Gentamicin so that it can be inhaled for outpatient use. Gentamicin currently can only be administered intravenously in a hospital. The…
Recommended
Trending
Congress Updates
NRO Nominee: “We Have To Look Differently At Our Requirements”
The National Reconnaissance Office (NRO) has said that it has launched more than 200 proliferated low Earth orbit satellites in the last two years to supplement the costly high-end systems […]
Congress Needed Pentagon’s Iran Supplemental Request ‘Yesterday,’ HASC’s Wittman Says
A senior member of the House Armed Services Committee (HASC) said Wednesday that Congress needed the Pentagon’s Iran supplemental funding request “yesterday,” noting the ongoing lack of details from the […]
Space Force Eyes Nearly $1.5 Billion for Space Data Network Backbone in Future Reconciliation Bill
The U.S. Space Force (USSF) plans to request nearly $1.5 billion for the Space Data Network (SDN) Backbone in a future fiscal 2027 reconciliation bill. Last week, Space Force’s Space […]
Warren And Sheehy Renew Call for “Right to Repair” In NDAA
Sen. Elizabeth Warren (D-Mass.) and Sen. Timothy Sheehy (R-Mont.), two members of the Senate Armed Services Committee (SASC), are renewing their call for “Right to Repair” language in the National […]
Job Feed
-
Dispatcher (CESE)
JSL TECHNOLOGIES INCORPORATED - Williamsburg, VA -
ADV000CO3 Portable Life Support System Project/Test Engineer (A)
Aerodyne Industries - Houston, TX -
ELECTRONICS TECHNICIAN, MAINTENANCE II
Reliance Test & Technology - Eglin AFB, FL -
Federal Personnel Assistant (Army experience a plus)
Infinisource Consulting Solutions - Salt Lake, UT